One Drop Announces Long-Term Outcomes Forecasts For Diabetes-Related Biomarkers And Overnight Hypoglycemia Predictions For CGM Users
One Drop leads the paradigm shift in health management from reactive to prospective, unveiling new AI-powered predictions for blood glucose, A1C, blood pressure, and weight up to six months in advance
NEW YORK, June 15, 2020 /PRNewswire/ -- One Drop, a leader in digital therapeutics solutions for people living with diabetes and other chronic conditions, presented long-term A1C, blood pressure, and weight outcomes forecasts for individuals, along with overnight hypoglycemia predictions for CGM users at the 80th Annual American Diabetes Association Virtual Scientific Sessions. New predictions lay the foundation for One Drop's highly personalized and adaptive data-driven health products.
One Drop | Real-TIme Glucose Forecasts (PRNewsfoto/One Drop)
Automated Decision Support delivers glucose predictions up to 12 hours in advance (PRNewsfoto/One Drop)
One Drop | Everything you need to manage your diabetes (PRNewsfoto/One Drop)
One Drop | Chrome (PRNewsfoto/One Drop)
To date, One Drop has collected more than 11 billion health data points from nearly 3 million One Drop app users in 195 countries. The app collects health data through manual input, automatic upload from connected devices, HealthKit, GoogleFit, and direct integrations with Dexcom, Fitbit, Apple Watch, Companion Medical, and other strategic partners. One Drop recently acquired the assets and intellectual property of Sano Intelligence, Inc. and announced plans to develop a multisensorial patch that will generate thousands of new data points per user per day.
This pooled population data powers the machine learning models behind One Drop's Predictive Insights. Currently, users can receive eight-hour glucose forecasts, along with real-time advice for exercise, diet, and lifestyle adjustments.
"The real power of our predictive models is how individualized they are," said One Drop VP of Data Science, Dan Goldner. "We don't bother looking for broad patterns of factors that might help in distinct groups. Instead, we jump straight to predicting the factors most likely to help you. We update that prediction every day and use that insight to steer your personal One Drop experience."
Treatment goals for diabetes and related conditions, including hypertension and prediabetes, are defined as reductions in average blood glucose concentration, blood pressure, and weight. Accurately predicting these metrics can enable the delivery of timely treatment and lifestyle recommendations, leading to improved outcomes.
In a recent study, One Drop trained a suite of patent-pending supervised learning models to accurately forecast changes in glucose, blood pressure, and weight up to six months in advance. Sources for the study included health and selfcare data from a sample of approximately 55,000 users [1].
"A reactive, symptom-focused approach to health is unsustainable," said One Drop CEO and founder, Jeff Dachis. "We cannot expect people living with chronic conditions to spend more and more on healthcare, year after year, but get less and less in return. We must enable everyone to become active participants in their health, not just recipients of services and advice. One Drop is leading the paradigm shift in health management from reactive to prospective, with our new short- and long-term predictions for diabetes-related biomarkers laying the foundation for affordable and highly personalized self-care products."
One Drop expects to release new predictions to subscribers within the year.
[1] Wexler Y, Goldner D, Merchant G. Hirsch A, Huddleston B, Dachis. One- to Six-Month Outcomes Forecasts for Diabetes and Related Conditions. Poster presented at: The 80th Annual American Diabetes Association Scientific Sessions; June 12, 2020; Virtual.
[2] Wexler Y, Goldner D, Merchant G. Hirsch A, Huddleston B, Dachis. One- to Six-Month Outcomes Forecasts for Diabetes and Related Conditions. Overnight Hypoglycemia Prediction for CGM Users. Poster presented at: The 80th Annual American Diabetes Association Scientific Sessions; June 12, 2020; Virtual.
About One Drop
One Drop is a digital health company harnessing the power of behavioral science, data science, and mobile computing to transform the lives of people with diabetes and other chronic conditions worldwide. Evidence-based and clinically effective, the One Drop app brings affordable, accessible self-care to every person with a smartphone, as well as their insurers, employers, and healthcare providers. One Drop leverages proprietary machine learning, advanced AI, and personal health coaching to deliver customized programs that promote positive behavior change and drive outcomes. Users can order supplies including the One Drop glucose meter, test strips, and lancets for home delivery directly from the One Drop app or online store. One Drop's consumer services are available for purchase in the award-winning One Drop app (iOS and Android), and at https://onedrop.today, Walmart, Amazon, BestBuy, and the Apple Store. For information on helping your organization lower the cost of care, contact [email protected].
Share this article